BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28799818)

  • 1. The Expression and Clinical Signification of PD-1 in Lymph Nodes of Patients with Non-small Cell Lung Cancer.
    Ma H; Mao G; Zhang G; Huang H
    Immunol Invest; 2017 Oct; 46(7):639-646. PubMed ID: 28799818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing PDL-1 and PD-1 in Non-Small Cell Lung Cancer: A Novel Immunoscore Approach.
    Paulsen EE; Kilvaer TK; Khanehkenari MR; Al-Saad S; Hald SM; Andersen S; Richardsen E; Ness N; Busund LT; Bremnes RM; Donnem T
    Clin Lung Cancer; 2017 Mar; 18(2):220-233.e8. PubMed ID: 27816392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas.
    Kim S; Kim MY; Koh J; Go H; Lee DS; Jeon YK; Chung DH
    Eur J Cancer; 2015 Nov; 51(17):2698-707. PubMed ID: 26329973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of CD4+ CD25+ regulatory T-cells detection in tumor-draining lymph nodes of nonsmall cell lung cancer patients].
    Su YJ; Ren K; Li H; Ren XB; Wang CL
    Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):922-6. PubMed ID: 18478932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups.
    Schmidt LH; Kümmel A; Görlich D; Mohr M; Bröckling S; Mikesch JH; Grünewald I; Marra A; Schultheis AM; Wardelmann E; Müller-Tidow C; Spieker T; Schliemann C; Berdel WE; Wiewrodt R; Hartmann W
    PLoS One; 2015; 10(8):e0136023. PubMed ID: 26313362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Message RNA expression of LUNX, CK19 and CEA genes in NSCLC with micrometastasis in lymph nodes].
    Wang WB; Cui YG; Yao SY
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):121-4. PubMed ID: 18646695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foxp3(+) regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma.
    Schneider T; Kimpfler S; Warth A; Schnabel PA; Dienemann H; Schadendorf D; Hoffmann H; Umansky V
    J Thorac Oncol; 2011 Mar; 6(3):432-8. PubMed ID: 21258248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of melanoma-antigen-A (MAGE-A) in disseminated tumor cells in regional lymph nodes of patients with operable non-small cell lung cancer.
    Dango S; Wang XT; Gold M; Cucuruz B; Klein CA; Passlick B; Sienel W
    Lung Cancer; 2010 Mar; 67(3):290-5. PubMed ID: 19467731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Up-regulation of TIM-3 on CD4+ tumor infiltrating lymphocytes predicts poor prognosis in human non-small-cell lung cancer].
    Ji P; Chen D; Bian J; Xia R; Song X; Wen W; Zhang X; Zhu Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jun; 31(6):808-11. PubMed ID: 26062425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the expression profiles of excision repair crosscomplementation group 1, x-ray repair crosscomplementation group 1, and betaIII-tubulin between primary non-small cell lung cancer and metastatic lymph nodes and the significance in mid-term survival.
    Kang CH; Jang BG; Kim DW; Chung DH; Kim YT; Jheon S; Sung SW; Kim JH
    J Thorac Oncol; 2009 Nov; 4(11):1307-12. PubMed ID: 19745766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [LUNX mRNA in regional lymph nodes of non-small cell lung cancer patients by RT-PCR and its clinical significance].
    Tan S; Cheng Z; Ma Y; Tan S; Yin Z; Hu W; Yu F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Dec; 35(12):1236-41. PubMed ID: 21200090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological study on nodal molecular staging of non-small-cell lung cancer].
    Wang YX; Sun YE; Li XH; Wang ZB; Liu YL; Chen LA; Zhang GK
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):161-4. PubMed ID: 17425845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases.
    Paulsen EE; Kilvaer TK; Rakaee M; Richardsen E; Hald SM; Andersen S; Busund LT; Bremnes RM; Donnem T
    Cancer Immunol Immunother; 2017 Nov; 66(11):1449-1461. PubMed ID: 28707078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can the condition of the cell microenvironment of mediastinal lymph nodes help predict the risk of metastases in non-small cell lung cancer?
    Zieliński P; Dyszkiewicz W; Piwkowski CT; Dworacki G; Gasiorowski L
    Cancer Epidemiol; 2009 Nov; 33(5):387-90. PubMed ID: 19931500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 on peripheral blood T lymphocytes is prognostic in patients with non-small cell lung cancer (NSCLC) treated with EGFR inhibitors.
    Meniawy TM; Lake RA; McDonnell AM; Millward MJ; Nowak AK
    Lung Cancer; 2016 Mar; 93():9-16. PubMed ID: 26898608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comprehensive Analysis of Programmed Cell Death Ligand-1 Expression With the Clone SP142 Antibody in Non-Small-Cell Lung Cancer Patients.
    Takada K; Toyokawa G; Okamoto T; Shimokawa M; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takamori S; Katsura M; Shoji F; Oda Y; Maehara Y
    Clin Lung Cancer; 2017 Sep; 18(5):572-582.e1. PubMed ID: 28318951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression levels of co-inhibitory molecules CTLA-4, LAG-3, PD-1 and CD39 on CD4⁺ T cells correlate with progression of non-small cell lung cancer].
    Wei T; Zhang J; Wu Y; Zhang D; Lu L; Shen Q
    Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):424-9. PubMed ID: 25241783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of PD-1 on CD4+ T cells in peripheral blood associates with poor clinical outcome in non-small cell lung cancer.
    Zheng H; Liu X; Zhang J; Rice SJ; Wagman M; Kong Y; Zhu L; Zhu J; Joshi M; Belani CP
    Oncotarget; 2016 Aug; 7(35):56233-56240. PubMed ID: 27191652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study on molecular staging of lymph nodes in non-small cell lung cancer patients].
    Wang YX; Sun YE; Li XH; Wang ZB; Tong XY; Liu YL
    Ai Zheng; 2009 Mar; 28(3):318-22. PubMed ID: 19619450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between VEGF-C expression in peripheral blood, lymph nodes and tumor tissues in patients with non-small cell lung cancer].
    Zeng HS; Guo QS; Guan Y
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):527-8. PubMed ID: 22093632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.